1-5 of 5
Gurmeet Kaur
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Editor's Note: Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator

Free
Gurmeet Kaur, Dorina Belotti, Angelika M. Burger, Kirsten Fisher-Nielson, Patrizia Borsotti, Elena Riccardi, Jagada Thillainathan, Melinda Hollingshead, Edward A. Sausville, Raffaella Giavazzi
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (9): 1996.
https://doi.org/10.1158/1078-0432.CCR-24-0857
Published: 01 May 2024
View articletitled, Editor's Note: Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator
Open the PDF for Editor's Note: Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator in another window
Journal Articles

Development of a quantitative enzyme immunoassay for measurement of PAR as a pharmacodynamic biomarker of PARP activity

Free
Robert J. Kinders, Joann Palma, Xuesong Liu, Milagros Colon-Lopez, Yan Luo, Luiz E. Rodriguez, Yan Shi, Ran Guan, Shimin Wei, Jennifer Low, Anthony Murgo, Oxana Pickerel, Shivaani Kumar, Martin Gutierrez, Larry Rubinstein, Sherry Yang, Jay Ji, Gurmeet Kaur, Ralph Parchment, Tiziano DiPaolo, Jerry Collins, Melinda Hollingshead, Joseph Tomaszewski, James Doroshow, Vincent Giranda
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19_Supplement): A5.
Published: 15 August 2014
View articletitled, Development of a quantitative enzyme immunoassay for measurement of PAR as a pharmacodynamic biomarker of PARP activity
Journal Articles

Transcriptional Profiling Identifies Altered Intracellular Labile Iron Homeostasis as a Contributing Factor to the Toxicity of Adaphostin: Decreased Vascular Endothelial Growth Factor Secretion Is Independent of Hypoxia-Inducible Factor-1 Regulation

Free
Curtis Hose, Gurmeet Kaur, Edward A. Sausville, Anne Monks
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (17): 6370–6381.
https://doi.org/10.1158/1078-0432.CCR-05-0291
Published: 06 September 2005
View articletitled, Transcriptional Profiling Identifies Altered Intracellular Labile Iron Homeostasis as a Contributing Factor to the Toxicity of Adaphostin: Decreased Vascular Endothelial Growth Factor Secretion Is Independent of Hypoxia-Inducible Factor-1 Regulation
Open the PDF for Transcriptional Profiling Identifies Altered Intracellular Labile Iron Homeostasis as a Contributing Factor to the Toxicity of Adaphostin: Decreased Vascular Endothelial Growth Factor Secretion Is Independent of Hypoxia-Inducible Factor-1 Regulation in another window
Journal Articles

Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator

Free
Gurmeet Kaur, Dorina Belotti, Angelika M. Burger, Kirsten Fisher-Nielson, Patrizia Borsotti, Elena Riccardi, Jagada Thillainathan, Melinda Hollingshead, Edward A. Sausville, Raffaella Giavazzi
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (14): 4813–4821.
https://doi.org/10.1158/1078-0432.CCR-03-0795
Published: 21 July 2004
View articletitled, Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator
Open the PDF for Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator in another window
Journal Articles

Effects of the bcr/abl Kinase Inhibitors AG957 and NSC 680410 on Chronic Myelogenous Leukemia Cells in Vitro

Free
Phyllis A. Svingen, Ayalew Tefferi, Timothy J. Kottke, Gurmeet Kaur, Ven L. Narayanan, Edward A. Sausville, Scott H. Kaufmann
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (1): 237–249.
Published: 01 January 2000
View articletitled, Effects of the bcr/abl Kinase Inhibitors AG957 and NSC 680410 on Chronic Myelogenous Leukemia Cells in Vitro
Open the PDF for Effects of the bcr/abl Kinase Inhibitors AG957 and NSC 680410 on Chronic Myelogenous Leukemia Cells in Vitro in another window